Sufi Mary Thomas

16PUBLICATIONS
27CO-AUTHORS
Radiation therapyCancer geneticsMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 13, 2026
Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy.

|May 19, 2025
TRIM16 mediates secretory autophagy in head and neck cancer-associated fibroblasts.

Thuc Ly, Bailey Pickard, Avisha Pandey

|Apr 21, 2025
Targeting FGFR Attenuates Tumor Growth in an Anal Squamous Cell Carcinoma Patient Derived Xenograft Model.

Thuc Ly, Athena E Golfinos-Owens, Naren Raja

|Jan 27, 2025
Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.

Sonali Sinha, Nidhi Dwivedi, Shixin Tao

|Nov 29, 2023
Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression.

Levi Arnold, Juan Pineda Gomez, Michael Barry

|Oct 11, 2022
Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma.

David Standing, Levi Arnold, Prasad Dandawate

Pageof 3

Frequent Collaborators

2 joint publications

Deri Morgan

2 joint publications

Thuc Ly

2 joint publications

Shrikant Anant

2 joint publications

Gregory N Gan